Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AVA6000 |
Synonyms | |
Therapy Description |
AVA6000 consists of a doxorubicin molecule covalently linked to a dipeptide that can be hydrolyzed by fibroblast activation protein alpha (FAP), potentially leading to release of doxorubicin in the tumor microenvironment and inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 1815). |